271 related articles for article (PubMed ID: 21613789)
21. MoCA, ACE-R, and MMSE versus the National Institute of Neurological Disorders and Stroke-Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards Neuropsychological Battery after TIA and stroke.
Pendlebury ST; Mariz J; Bull L; Mehta Z; Rothwell PM
Stroke; 2012 Feb; 43(2):464-9. PubMed ID: 22156700
[TBL] [Abstract][Full Text] [Related]
22. Screening for cognitive deficits in Parkinson's disease with the Parkinson neuropsychometric dementia assessment (PANDA) instrument.
Kalbe E; Calabrese P; Kohn N; Hilker R; Riedel O; Wittchen HU; Dodel R; Otto J; Ebersbach G; Kessler J
Parkinsonism Relat Disord; 2008; 14(2):93-101. PubMed ID: 17707678
[TBL] [Abstract][Full Text] [Related]
23. The MoCA: well-suited screen for cognitive impairment in Parkinson disease.
Dalrymple-Alford JC; MacAskill MR; Nakas CT; Livingston L; Graham C; Crucian GP; Melzer TR; Kirwan J; Keenan R; Wells S; Porter RJ; Watts R; Anderson TJ
Neurology; 2010 Nov; 75(19):1717-25. PubMed ID: 21060094
[TBL] [Abstract][Full Text] [Related]
24. Brief screening tool for mild cognitive impairment in older Japanese: validation of the Japanese version of the Montreal Cognitive Assessment.
Fujiwara Y; Suzuki H; Yasunaga M; Sugiyama M; Ijuin M; Sakuma N; Inagaki H; Iwasa H; Ura C; Yatomi N; Ishii K; Tokumaru AM; Homma A; Nasreddine Z; Shinkai S
Geriatr Gerontol Int; 2010 Jul; 10(3):225-32. PubMed ID: 20141536
[TBL] [Abstract][Full Text] [Related]
25. Clinical validation of Movement Disorder Society-recommended diagnostic criteria for Parkinson's disease with dementia.
Barton B; Grabli D; Bernard B; Czernecki V; Goldman JG; Stebbins G; Dubois B; Goetz CG
Mov Disord; 2012 Feb; 27(2):248-53. PubMed ID: 22162144
[TBL] [Abstract][Full Text] [Related]
26. Characterizing mild cognitive impairment in Parkinson's disease.
Dalrymple-Alford JC; Livingston L; MacAskill MR; Graham C; Melzer TR; Porter RJ; Watts R; Anderson TJ
Mov Disord; 2011 Mar; 26(4):629-36. PubMed ID: 21287603
[TBL] [Abstract][Full Text] [Related]
27. Cognitive characteristics associated with mild cognitive impairment in Parkinson's disease.
McKinlay A; Grace RC; Dalrymple-Alford JC; Roger D
Dement Geriatr Cogn Disord; 2009; 28(2):121-9. PubMed ID: 19690414
[TBL] [Abstract][Full Text] [Related]
28. Defining mild cognitive impairment in Parkinson's disease.
Caviness JN; Driver-Dunckley E; Connor DJ; Sabbagh MN; Hentz JG; Noble B; Evidente VG; Shill HA; Adler CH
Mov Disord; 2007 Jul; 22(9):1272-7. PubMed ID: 17415797
[TBL] [Abstract][Full Text] [Related]
29. Addenbrooke's Cognitive Examination-Revised for mild cognitive impairment in Parkinson's disease.
McColgan P; Evans JR; Breen DP; Mason SL; Barker RA; Williams-Gray CH
Mov Disord; 2012 Aug; 27(9):1173-7. PubMed ID: 22733390
[TBL] [Abstract][Full Text] [Related]
30. Functional ability correlates with cognitive impairment in Parkinson's disease and Alzheimer's disease.
Sabbagh MN; Lahti T; Connor DJ; Caviness JN; Shill H; Vedders L; Mahant P; Samanta J; Burns RS; Evidente VG; Driver-Dunckley E; Reisberg B; Bircea S; Adler CH
Dement Geriatr Cogn Disord; 2007; 24(5):327-34. PubMed ID: 17851237
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic utility of the Addenbrooke's Cognitive Examination - III (ACE-III), Mini-ACE, Mini-Mental State Examination, Montreal Cognitive Assessment, and Hasegawa Dementia Scale-Revised for detecting mild cognitive impairment and dementia.
Senda M; Terada S; Takenoshita S; Hayashi S; Yabe M; Imai N; Horiuchi M; Yamada N
Psychogeriatrics; 2020 Mar; 20(2):156-162. PubMed ID: 31448862
[TBL] [Abstract][Full Text] [Related]
32. Subtypes of mild cognitive impairment in Parkinson's disease: progression to dementia.
Janvin CC; Larsen JP; Aarsland D; Hugdahl K
Mov Disord; 2006 Sep; 21(9):1343-9. PubMed ID: 16721732
[TBL] [Abstract][Full Text] [Related]
33. Cognitive impairment in Parkinson's disease: tools for diagnosis and assessment.
Kulisevsky J; Pagonabarraga J
Mov Disord; 2009 Jun; 24(8):1103-10. PubMed ID: 19353727
[TBL] [Abstract][Full Text] [Related]
34. Montreal Cognitive Assessment for the screening and prediction of cognitive decline in early Parkinson's disease.
Kandiah N; Zhang A; Cenina AR; Au WL; Nadkarni N; Tan LC
Parkinsonism Relat Disord; 2014 Nov; 20(11):1145-8. PubMed ID: 25176439
[TBL] [Abstract][Full Text] [Related]
35. Validation of the Addenbrooke's cognitive examination for detecting early Alzheimer's disease and mild vascular dementia in a German population.
Alexopoulos P; Greim B; Nadler K; Martens U; Krecklow B; Domes G; Herpertz S; Kurz A
Dement Geriatr Cogn Disord; 2006; 22(5-6):385-91. PubMed ID: 16960447
[TBL] [Abstract][Full Text] [Related]
36. Screening for cognitive dysfunction in corticobasal syndrome: utility of Addenbrooke's cognitive examination.
Mathew R; Bak TH; Hodges JR
Dement Geriatr Cogn Disord; 2011; 31(4):254-8. PubMed ID: 21474935
[TBL] [Abstract][Full Text] [Related]
37. A Validation Study of the Chinese Version of the Mini-Addenbrooke's Cognitive Examination for Screening Mild Cognitive Impairment and Mild Dementia.
Yang L; Li X; Yin J; Yu N; Liu J; Ye F
J Geriatr Psychiatry Neurol; 2019 Jul; 32(4):205-210. PubMed ID: 30987514
[TBL] [Abstract][Full Text] [Related]
38. Comparison of the short test of mental status and the mini-mental state examination in mild cognitive impairment.
Tang-Wai DF; Knopman DS; Geda YE; Edland SD; Smith GE; Ivnik RJ; Tangalos EG; Boeve BF; Petersen RC
Arch Neurol; 2003 Dec; 60(12):1777-81. PubMed ID: 14676056
[TBL] [Abstract][Full Text] [Related]
39. Addenbrooke's cognitive examination III: diagnostic utility for detecting mild cognitive impairment and dementia in Parkinson's disease.
Sousa NMF; Brucki SMD
Arq Neuropsiquiatr; 2023 Feb; 81(2):155-163. PubMed ID: 36863401
[TBL] [Abstract][Full Text] [Related]
40. [Neuropsychological impairment in Parkinson's disease without dementia].
Marañón D; Amayra I; Uterga JM; Gómez-Esteban JC
Psicothema; 2011 Nov; 23(4):732-7. PubMed ID: 22047866
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
